Nycomed: Clinical Trials

13 trials sponsored by Nycomed, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed. 13 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 313Completed 13

Follow Nycomed: new trials by email

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke.
citicoline, L-Alpha glycerylphosphorylcholine, cerebrolysin - Stroke
Phase 3CompletedClinical Institute of the Brain, Russia302011-01-012011-12-23
Bupivacaine Effectiveness and Safety in SABER® Trial
SABER-Bupivacaine, Bupivacaine HCl, SABER-Placebo - Postoperative Pain, Abdominal Surgery
Phase 3CompletedDurect3312009-12-012021-06-01
Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects
teduglutide, placebo - Short Bowel Syndrome
Phase 3CompletedShire862008-11-252021-06-03
Comparison of Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq) in Cancer Breakthrough Pain (FT-019-IM)
Nasal fentanyl - Pain
Phase 3CompletedNycomed1152007-01-012012-05-07
Actovegin® Versus Placebo in Patients With Diabetic Polyneuropathy (AV-007-IM)
Deproteinised hemoderivative of calf blood (Actovegin) - Symptomatic Diabetic Peripheral Polyneuropathy
Phase 3CompletedNycomed5692006-12-012012-05-07
Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease (BY1023/DE-004)
Pantoprazole - Gastroesophageal Reflux
Phase 3CompletedNycomed292006-10-012012-05-07
Efficacy and Safety of Intranasal Fentanyl in the Treatment of Breakthrough Pain (FT-018-IM)
Fentanyl - Cancer
Phase 3CompletedNycomed1002006-06-012012-05-07
Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)
pantoprazole sodium enteric-coated spheroid - Gastroesophageal Reflux
Phase 3CompletedWyeth is now a wholly owned subsidiary of Pfizer602006-05-012026-09-25
TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM)
Fibrinogen (human) + thrombin (human) (TachoSil) - Pulmonary Diseases, Intraoperative Complications
Phase 3CompletedNycomed2006-02-012012-05-07
Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD
pantoprazole sodium enteric-coated spheroid suspension - Gastroesophageal Reflux
Phase 3CompletedWyeth is now a wholly owned subsidiary of Pfizer672005-11-012010-05-07
TachoSil Paediatric Liver Trial (TC-019-IN)
Fibrinogen human (TachoSil) - Liver Diseases
Phase 3CompletedNycomed162005-10-012012-05-07
Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN)
Fentanyl (Matrifen) - Standard Opioid Analgesic Treatment of Cancer-related Chronic Pain.
Phase 3CompletedNycomed2202004-09-012012-05-07
Fibrin Glue for Perianal Fistulas in Crohn's Disease: a Randomized Controlled Trial
Fibrin glue injection in fistula - Crohn's Disease
Phase 3CompletedGroupe d'Etude Therapeutique des Affections Inflammatoires Digestives772003-11-012011-09-05

Conditions studied

Gastroesophageal Reflux (3)  ·  Crohn Disease (1)  ·  Hyperphagia (1)  ·  Intraoperative Complications (1)  ·  Ischemic Stroke (1)  ·  Liver Diseases (1)  ·  Lung Diseases (1)  ·  Neoplasms (1)  ·  Pain (1)  ·  Pain, Postoperative (1)  ·  Short Bowel Syndrome (1)  ·  Stroke (1)

Interventions

Fentanyl (2)  ·  Fibrinogen (2)  ·  TachoSil (2)  ·  ALX-0600 (1)  ·  Actovegin (1)  ·  Bupivacaine (1)  ·  Cytidine Diphosphate Choline (1)  ·  Fibrin Tissue Adhesive (1)  ·  Glycerylphosphorylcholine (1)  ·  Pantoprazole (1)  ·  Thrombin (1)  ·  cerebrolysin (1)  ·  teduglutide (1)

Countries

Denmark (6)  ·  United States (4)  ·  France (3)  ·  Germany (3)  ·  Australia (2)  ·  Belgium (2)  ·  Canada (2)  ·  Italy (2)  ·  Poland (2)  ·  Netherlands (1)  ·  New Zealand (1)  ·  Russia (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Dmitri Lissin, MD (1)

Results publications

PMID 16099790, PMID 19792837, PMID 20178792, PMID 20522615, PMID 21740077, PMID 22982184, PMID 23274148, PMID 23587733, PMID 24134154, PMID 27507402, PMID 29174926, PMID 31784300

NIH funding

2004 (2), 2005 (1), 2008 (1)